3EO Health COVID Test Gets FDA Emergency Use Authorization
3EO Health announced the receipt of an FDA emergency use authorization (EUA) for its SARS-CoV-2 molecular test.
Read MorePosted by Andy Lundin | Oct 20, 2023 | Covid 19 |
3EO Health announced the receipt of an FDA emergency use authorization (EUA) for its SARS-CoV-2 molecular test.
Read MorePosted by Andy Lundin | Oct 20, 2023 | Diagnostic Technologies |
WHO updated its Essential Diagnostics List, a register of in vitro diagnostics supporting countries to make national diagnostic choices.
Read MorePosted by Andy Lundin | Oct 18, 2023 | Company News, Flu & Respiratory Infections |
Evidation has been awarded a contract by BARDA to fund the 2023 Influenza-like Illness (ILI) Detect & Protect Studies.
Read MorePosted by Andy Lundin | Oct 12, 2023 | Infectious Diseases |
Researchers developed a new AI tool that was designed to make predictions about new viral variants before they actually emerge.
Read MorePosted by Eli Patterson | Oct 11, 2023 | Gastrointestinal Infections, Sponsored |
COVID-19 has reshaped the global landscape of gastrointestinal infections, notably surging norovirus cases. Coupled with an increasing immunity gap due to reduced vaccinations, healthcare systems are on alert. Seegene offers solutions for these unprecedented challenges.
Read More